作者
Yutaka Matsui, Nan Jia, Hiroshi Okamoto, Shigeyuki Kon, Hisao Onozuka, Masatoshi Akino, Lizhi Liu, Junko Morimoto, Susan R Rittling, David Denhardt, Akira Kitabatake, Toshimitsu Uede
发表日期
2004/6/1
期刊
Hypertension
卷号
43
期号
6
页码范围
1195-1201
出版商
Lippincott Williams & Wilkins
简介
Osteopontin (OPN) is upregulated in several experimental models of cardiac fibrosis and remodeling. However, its direct effects remain unclear. We examined the hypothesis that OPN is important for the development of cardiac fibrosis and remodeling. Moreover, we examined whether the inhibitory effect of eplerenone (Ep), a novel aldosterone receptor antagonist, was mediated through the inhibition of OPN expression against cardiac fibrosis and remodeling. Wild-type (WT) and OPN-deficient mice were treated with angiotensin II (Ang II) for 4 weeks. WT mice receiving Ang II were divided into 2 groups: a control group and an Ep treatment group. Ang II treatment significantly elevated blood pressure and caused cardiac hypertrophy and fibrosis in WT mice. Ep treatment and OPN deficiency could reduce the Ang II-induced elevation of blood pressure and ameliorate the development of cardiac fibrosis, whereas Ep …
引用总数
200420052006200720082009201020112012201320142015201620172018201920202021202220232024711101414914161310169811710861272